Cervix News and Research

RSS

From simple ovulation treatments to IVF, how doctors choose the right approach

A clinical review on female infertility discusses causes, IVF options, and complications, equipping clinicians to improve patient care and treatment outcomes.

2 Nov 2026

Understanding the symptoms and treatments of pelvic organ prolapse

The pelvic floor is a layer of muscles and connective tissues that supports the uterus, bladder, urethra, vagina and rectum. The pelvic floor supports the organs in your pelvis from underneath, almost like a hammock.

26 Oct 2026

Researchers harness cancer cells' carbon monoxide to produce anticancer drug

What if we could use a cancer's own byproduct to make drugs that destroy tumor cells from the inside? That is exactly what Katsunori Tanaka and his team have done at the RIKEN Pioneering Research Institute (PRI) in Japan.

23 Oct 2026

HPV vaccines protect against cancer. Could they benefit pregnancy?

Findings from a nationwide study suggest HPV vaccination may reduce adverse pregnancy outcomes, emphasizing its importance in reproductive health strategies.

12 Oct 2026

Infections caused 1 in 8 cancer cases worldwide in 2024, study finds

Infections drove 1 in 8 cancer cases worldwide in 2024, study finds.

9 Oct 2026

Review outlines key strategies to reduce gynecologic cancer-related mortality

Low- and middle-income countries (LMICs) bear a disproportionate burden of gynecologic malignancies-cancers of the cervix, endometrium, ovary, vagina, and vulva.

24 Aug 2026

Experts call for better trials as IVF preparation techniques show unproven results

Preparation techniques used before embryo transfer, considered the most critical step in the IVF process, show no proven effect on pregnancy rates and remain inconclusive due to limited or low-quality data, a new Cochrane review finds.

6 Aug 2026

Phase 3 clinical trial enrolls first platinum-resistant ovarian cancer patient

The GOG Foundation, Inc. is proud to announce the enrollment of the first patient in GOG-3132/BEHOLD-Ovarian01 (NCT07286266), a global Phase 3 clinical trial titled A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants with Platinum-resistant Ovarian Cancer.

27 Jul 2026

Diverse cancer subtypes can originate from a single progenitor cell

How do different cancer subtypes arise? Do they originate from distinct cells, or from a single multipotent cell capable of differentiating into multiple cell types?

4 Jun 2026

RNA regulator RBM15 linked to immunity, metabolism, and cancer progression

A newly published review article brings attention to the expanding role of RBM15, a critical regulator of RNA m6A methylation, in the development and progression of a wide range of diseases, including cancer, metabolic disorders, and cardiovascular conditions.

24 May 2026

Excess EXO1 protein may drive cancer DNA damage and treatment response

When it comes to cancer, tumor suppressor genes are usually thought of as the "good guys." These genes make proteins that protect and repair DNA in cells.

21 May 2026

International trial proves AI can design gold-standard cancer treatment plans

An AI technology is effective at planning the delivery of life-saving radiotherapy for cervical cancer and prostate cancer, according to results from a large international trial led by researchers at University College London (UCL) and the London School of Hygiene & Tropical Medicine (LSHTM).

18 May 2026

New research maps the biological toll of drinking

A new review published in the journal Addiction confirms drinking causes substantial harm to health. Some of those harms may be reversible if the person reduces or stops drinking.

14 May 2026

AI-powered handheld microscope may improve early cancer detection

Researchers at Rice University and The University of Texas MD Anderson Cancer Center have developed a compact, artificial intelligence-powered imaging device that could transform how clinicians detect cancer.

12 May 2026

Injectable immunotherapy shrinks precancerous oral lesions in clinical trial

Injecting nivolumab (Opdivo) directly into precancerous oral lesions led to reduction in lesion size and allowed some patients to avoid surgery, according to research from a phase I clinical trial presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, held April 17-22.

21 Apr 2026